Dr. Raymond S. Greenberg joined The University of Texas System as Executive Vice Chancellor for Health Affairs on September 9, 2013. He is responsible for the six UT System health institutions and their aggregate operating budget of about $8.9 billion in 2015. Before coming to the UT System, Dr. Greenberg served for 13 years as president of the Medical University of South Carolina (MUSC) – the state’s preeminent, research-intensive academic health institutions. Prior to that, he served for five years as vice president for academic affairs and provost of MUSC, which is composed of six colleges and multiple hospital facilities. After receiving his undergraduate training from the University of North Carolina, Greenberg earned a medical degree from Duke University, a master’s of public health degree from Harvard University, and a doctorate in epidemiology from the University of North Carolina. Greenberg also holds honorary degrees from the College of Charleston, Simpson College and The Citadel. Following his training, Greenberg served for 12 years at Emory University, where he held several leadership positions, including chair of the medical school’s department of epidemiology and biostatistics, deputy director of the Winship Cancer Center and founding dean of the Rollins School of Public Health. Under Dr. Greenberg’s guidance, MUSC successfully competed for a National Cancer Institute-designated cancer center and a National Institutes of Health clinical and translational science award. In addition, Dr. Greenberg provided leadership in the design and construction of a variety of education, research and clinical facilities including a state-of-the-art hospital, and completed a record-breaking fund raising campaign. Nationally recognized for his research on cancer, Dr. Greenberg has served on many scientific advisory boards and holds two honorary doctorates.: For the past 6 years, Dr. Greenberg has served on the Board of Directors of the Association of Academic Health Centers, most recently as Chair-Elect, and then Chair.